Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 29,121 | 27,049 | 18,040 | 10,199 | 6,610 |
| Cost of Goods | 18,070 | 17,104 | 14,098 | 8,453 | 4,925 |
| Gross Profit | 11,051 | 9,945 | 3,942 | 1,746 | 1,685 |
| Operating Expenses | 29,743 | 26,773 | 25,417 | 21,408 | 11,072 |
| Operating Income | -18,622 | -16,724 | -21,377 | -19,209 | -8,462 |
| Interest Expense | 2,128 | 454 | 344 | 473 | 2,388 |
| Other Income | -2,209 | 1,375 | 353 | 689 | -2,187 |
| Pre-tax Income | -22,959 | -15,803 | -21,368 | -18,993 | -13,037 |
| Income Tax | -2,079 | N/A | -1,184 | -2,350 | -664 |
| Net Income Continuous | -20,880 | -15,803 | -20,184 | -16,643 | -12,373 |
| Net Income | $-20,880 | $-15,803 | $-20,184 | $-16,643 | $-12,373 |
| EPS Basic Total Ops | -151.65 | -150.15 | -294.29 | -264.26 | -397.90 |
| EPS Basic Continuous Ops | -151.73 | -149.60 | -294.29 | -264.47 | -398.24 |
| EPS Diluted Total Ops | -151.65 | -150.15 | -294.29 | -270.27 | -546.55 |
| EPS Diluted Continuous Ops | -151.73 | -149.60 | -294.26 | -264.10 | -397.31 |
| EPS Diluted Before Non-Recurring Items | -118.62 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-15,158 | $-14,337 | $-19,707 | $-18,060 | $-6,941 |